Press Releases Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Market Closed - Nasdaq Other stock markets 02:00:00 07/05/2024 am IST			5-day change	1st Jan Change
27.86 ^USD	+0.98%		+7.28%	+22.95%

14/03	Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating	MT
13/03	Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anika Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	08:12pm	AQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04/05	GL
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024	19/04	GL
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference	02/04	GL
Anika: Q4 Earnings Snapshot	14/03	AQ
Anika Reports Fourth Quarter and Year-End 2023 Financial Results	14/03	AQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	09/03	GL
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024	28/02	GL
Anika Highlights Its Recently Launched IntegrityTM Implant System and RevoMotionTM Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products during the 2024 AAOS Annual Meeting	14/02	AQ
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting	13/02	GL
Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release	29/11	AQ
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release	28/11	GL
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release	28/11	AQ
Anika to Participate in Upcoming Investor Conferences	08/11	GL
Anika: Q3 Earnings Snapshot	03/11	AQ
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business	03/11	AQ
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023	10/23/10	GL
Anika Announces the Full Market Release of the RevoMotion Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit, Evolving Technologies Annual Meeting	20/23/20	AQ
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting	19/23/19	GL
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting	19/23/19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Press Releases

Filters